FRESENIUS MEDICAL CARE-ADR (FMS) Stock Overview
USA - NYSE:FMS - US3580291066 - ADR
FMS Key Statistics, Chart & Performance
The current stock price of FMS is 26.7994 USD. In the past month the price increased by 9.46%. In the past year, price increased by 28.55%.
FMS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 12.4 | 99.73B | ||
| CI | THE CIGNA GROUP | 11.18 | 83.86B | ||
| LH | LABCORP HOLDINGS INC | 18.43 | 23.19B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.96 | 20.06B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 132.85 | 17.42B | ||
| HIMS | HIMS & HERS HEALTH INC | 71.61 | 12.95B | ||
| DVA | DAVITA INC | 13.68 | 9.48B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.89B | ||
| CHE | CHEMED CORP | 19.82 | 6.46B | ||
| RDNT | RADNET INC | 219.33 | 6.07B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 38.92 | 5.10B | ||
| OPCH | OPTION CARE HEALTH INC | 20.4 | 4.47B |
Related stock screener links
About FMS
Company Profile
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 112,445 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Company Info
FRESENIUS MEDICAL CARE-ADR
Else-Kroener-Strasse 1
Bad Homburg vor der Hohe HESSEN 61352 DE
CEO: Rice Powell
Employees: 112445
Phone: 4961726090
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the stock price of FRESENIUS MEDICAL CARE-ADR today?
The current stock price of FMS is 26.7994 USD. The price increased by 0.71% in the last trading session.
What is the ticker symbol for FRESENIUS MEDICAL CARE-ADR stock?
The exchange symbol of FRESENIUS MEDICAL CARE-ADR is FMS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is FMS stock listed?
FMS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for FRESENIUS MEDICAL CARE-ADR stock?
25 analysts have analysed FMS and the average price target is 30.05 USD. This implies a price increase of 12.11% is expected in the next year compared to the current price of 26.7994. Check the FRESENIUS MEDICAL CARE-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FRESENIUS MEDICAL CARE-ADR worth?
FRESENIUS MEDICAL CARE-ADR (FMS) has a market capitalization of 15.73B USD. This makes FMS a Large Cap stock.
How many employees does FRESENIUS MEDICAL CARE-ADR have?
FRESENIUS MEDICAL CARE-ADR (FMS) currently has 112445 employees.
What are the support and resistance levels for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a support level at 25.86 and a resistance level at 29.02. Check the full technical report for a detailed analysis of FMS support and resistance levels.
Is FRESENIUS MEDICAL CARE-ADR (FMS) expected to grow?
The Revenue of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 1.46% in the next year. Check the estimates tab for more information on the FMS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy FRESENIUS MEDICAL CARE-ADR (FMS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FMS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FMS, evaluating the profitability, health, valuation and growth aspects
- FRESENIUS MEDICAL CARE-ADR (FMS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FRESENIUS MEDICAL CARE-ADR (FMS) Sales and EPS estimates to see what analysts future expectations are.
- FRESENIUS MEDICAL CARE-ADR (FMS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FRESENIUS MEDICAL CARE-ADR (FMS) Insider and Institutional Ownership to learn about the owners and their transactions.
- FRESENIUS MEDICAL CARE-ADR (FMS) Stock Chart to make your own analysis
- FRESENIUS MEDICAL CARE-ADR (FMS) Latest news and press-releases to stay up to date.
Does FRESENIUS MEDICAL CARE-ADR (FMS) stock pay dividends?
FRESENIUS MEDICAL CARE-ADR (FMS) has a dividend yield of 3.34%. The yearly dividend amount is currently 0.69. Check the full fundamental report for a detailed analysis of FMS dividend history, reliability and sustainability.
When does FRESENIUS MEDICAL CARE-ADR (FMS) report earnings?
FRESENIUS MEDICAL CARE-ADR (FMS) will report earnings on 2025-11-04.
What is the Price/Earnings (PE) ratio of FRESENIUS MEDICAL CARE-ADR (FMS)?
The PE ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 13.07. This is based on the reported non-GAAP earnings per share of 2.05 and the current share price of 26.7994 USD. Check the full fundamental report for a full analysis of the valuation metrics for FMS.
What is the Short Interest ratio of FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The outstanding short interest for FRESENIUS MEDICAL CARE-ADR (FMS) is 0.36% of its float. Check the ownership tab for more information on the FMS short interest.
FMS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to FMS. When comparing the yearly performance of all stocks, FMS is one of the better performing stocks in the market, outperforming 70.96% of all stocks.
FMS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to FMS. FMS has an average financial health and profitability rating.
FMS Financial Highlights
Over the last trailing twelve months FMS reported a non-GAAP Earnings per Share(EPS) of 2.05. The EPS increased by 17.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.36% | ||
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| Debt/Equity | 0.71 |
FMS Forecast & Estimates
25 analysts have analysed FMS and the average price target is 30.05 USD. This implies a price increase of 12.11% is expected in the next year compared to the current price of 26.7994.
For the next year, analysts expect an EPS growth of 17.76% and a revenue growth 1.46% for FMS